Adage Capital Partners
ROIV icon

Adage Capital Partners’s Roivant Sciences ROIV Stock Holding History

Adage Capital Partners’s Portfolio ROIV Stock Details ROIV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$366M Sell
10,349,328
-2,444,769
-19% -$72.2M 0.51% 29
2026
Q1 		$354M Buy
12,794,097
+2,116,203
+20% +$54.4M 0.55% 26
2025
Q4 		$232M Buy
10,677,894
+3,445,511
+48% +$68M 0.35% 44
2025
Q3 		$109M Buy
7,232,383
+5,150,000
+247% +$63.8M 0.17% 114
2025
Q2 		$23.5M Sell
2,082,383
-1,737,600
-45% -$18.8M 0.04% 401
2025
Q1 		$38.5M Sell
3,819,983
-1,900,000
-33% -$20.5M 0.07% 284
2024
Q4 		$67.7M Sell
5,719,983
-34,752
-0.6% -$411K 0.12% 169
2024
Q3 		$66.4M Buy
5,754,735
+1,819,983
+46% +$20.7M 0.12% 187
2024
Q2 		$41.6M Hold
3,934,752
– – 0.08% 249
2024
Q1 		$41.5M Sell
3,934,752
-1,340,248
-25% -$14.5M 0.08% 270
2023
Q4 		$59.2M Sell
5,275,000
-925,000
-15% -$9.01M 0.12% 175
2023
Q3 		$72.4M Sell
6,200,000
-4,890,300
-44% -$55.3M 0.16% 142
2023
Q2 		$112M Sell
11,090,300
-3,790,625
-25% -$33.9M 0.24% 97
2023
Q1 		$110M Buy
14,880,925
+5,882,486
+65% +$48.4M 0.25% 98
2022
Q4 		$71.9M Buy
8,998,439
+5,298,439
+143% +$29.5M 0.17% 145
2022
Q3 		$11.9M Buy
3,700,000
+2,700,000
+270% +$10.5M 0.03% 588
2022
Q2 		$4.07M Buy
+1,000,000
New +$3.97M 0.01% 823

Other funds holding ROIV

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
QF
QVT Financial New York $1.7B AUM 173.77% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
UBS Group
UBS Group Zurich, Switzerland $786B AUM 40.34% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return

Adage Capital Partners's ROIV Position: Q2 2026 in Review

Adage Capital Partners reduced its Roivant Sciences (ROIV) stake by 19% in Q2 2026, selling an estimated $72.2M and leaving 10,349,328 shares worth $366M. The position accounts for 0.51% of the portfolio, ranked #29.

Adage Capital Partners first reported a position in ROIV in Q2 2022 and has held it in 17 quarters since. 499 funds tracked by Wall St. Rank hold ROIV as of Q2 2026.

  • Adage Capital Partners held 10,349,328 shares of Roivant Sciences worth $366M as of Q2 2026.
  • Adage Capital Partners sold 2,444,769 Roivant Sciences shares in Q2 2026, an estimated $72.2M.
  • Roivant Sciences made up 0.51% of Adage Capital Partners's portfolio in Q2 2026, its #29 holding.
  • Adage Capital Partners first reported a position in Roivant Sciences in Q2 2022 and has held it in 17 quarters since.
  • 499 funds tracked by Wall St. Rank held Roivant Sciences as of Q2 2026.

Based on Adage Capital Partners's 13F filing for Q2 2026, filed 14 Aug 2026.